UnitedHealth Group Incorporated $UNH Holdings Lessened by Vantage Investment Partners LLC

Key Points

• Vantage Investment Partners reduced its UnitedHealth stake by 5.1% in the third quarter, selling 14,177 shares and retaining 261,914 shares valued at approximately $96.1 million. Institutional investors collectively own 87.86% of UNH.
• UnitedHealth reported quarterly earnings of $4.69 per share, beating estimates of $4.14, while revenue reached $112.7 billion. Analysts maintain a “Moderate Buy” consensus with an average price target of $463.93.
• Long-term earnings expectations and some analyst price targets increased, but investor risks remain due to medical-cost and margin pressures, shareholder legal inquiries, and mixed near-term forecasts.

Vantage Investment Partners LLC lessened its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 5.1% during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 261,914 shares of the healthcare conglomerate's stock after selling 14,177 shares during the quarter. UnitedHealth Group makes up about 5.8% of Vantage Investment Partners LLC's investment portfolio, making the stock its 4th largest position. Vantage Investment Partners LLC's holdings in UnitedHealth Group were worth $96,143,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the stock. BlackRock Inc. increased its holdings in UnitedHealth Group by 4.6% in the 2nd quarter. BlackRock Inc. now owns 76,863,061 shares of the healthcare conglomerate's stock valued at $31,946,594,000 after acquiring an additional 3,395,530 shares during the last quarter. State Street Corp boosted its holdings in shares of UnitedHealth Group by 0.7% during the 2nd quarter. State Street Corp now owns 45,633,267 shares of the healthcare conglomerate's stock valued at $18,966,555,000 after purchasing an additional 301,081 shares during the last quarter. Bank of New York Mellon Corp grew its position in shares of UnitedHealth Group by 6.1% during the second quarter. Bank of New York Mellon Corp now owns 10,704,994 shares of the healthcare conglomerate's stock valued at $4,449,317,000 after purchasing an additional 616,723 shares in the last quarter. Wellington Management Group LLP grew its position in shares of UnitedHealth Group by 5.8% during the second quarter. Wellington Management Group LLP now owns 10,675,175 shares of the healthcare conglomerate's stock valued at $4,436,923,000 after purchasing an additional 583,536 shares in the last quarter. Finally, Corient Private Wealth LP increased its holdings in shares of UnitedHealth Group by 1,443.7% in the second quarter. Corient Private Wealth LP now owns 8,447,224 shares of the healthcare conglomerate's stock worth $3,510,920,000 after purchasing an additional 7,900,011 shares during the last quarter. Institutional investors own 87.86% of the company's stock.

Key UnitedHealth Group News

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Long-term earnings estimates increased. Zacks Research raised its FY2027 EPS forecast to $23.29 from $22.28 and its FY2028 estimate to $26.60 from $25.74, signaling improved expectations for UnitedHealth’s future profitability.
• Positive Sentiment: Morgan Stanley lifted its price target. The firm increased its target to $531 from $529 and maintained an “Overweight” rating, implying substantial potential upside from recent trading levels. Morgan Stanley Adjusts Price Target on UnitedHealth Group
• Neutral Sentiment: Near-term estimates were mixed. Zacks raised its Q2 2027 EPS forecast to $6.62 from $6.35, but slightly reduced its Q4 2026 estimate to $2.24 from $2.25. Zacks continues to rate UNH “Hold,” indicating limited conviction despite stronger longer-term projections.
• Neutral Sentiment: Fraud-prevention collaboration highlights operational opportunities. UnitedHealth and Codoxo plan to present AI-based methods for identifying healthcare fraud beyond traditional claims data. The initiative could support payment integrity and cost control, though it is not expected to materially affect near-term results. Codoxo and UnitedHealth Group fraud presentation
• Negative Sentiment: Investor uncertainty remains elevated. A law firm is soliciting shareholders over allegations concerning potential insider fiduciary-duty violations. The notice does not establish wrongdoing, but such announcements can add reputational and legal-risk concerns. UnitedHealth shareholder legal notice
• Negative Sentiment: Industry margin pressure remains a concern. A comparison with Molina Healthcare points to elevated medical costs and membership-related pressure across managed-care companies, factors that could weigh on UnitedHealth’s near-term margins even as its recent earnings exceeded expectations. Molina Healthcare versus Elevance Health and UnitedHealth

Insider Activity

In related news, CEO Patrick Conway sold 1,169 shares of UnitedHealth Group stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $390.00, for a total transaction of $455,910.00. Following the completion of the transaction, the chief executive officer directly owned 15,328 shares of the company's stock, valued at approximately $5,977,920. The trade was a 7.09% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 0.19% of the company's stock.

UnitedHealth Group Price Performance

NYSE:UNH opened at $406.81 on Thursday. The firm has a market capitalization of $365.15 billion, a price-to-earnings ratio of 23.23, a PEG ratio of 1.51 and a beta of 0.60. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.74 and a quick ratio of 0.78. The business has a 50 day simple moving average of $389.32 and a 200-day simple moving average of $361.74. UnitedHealth Group Incorporated has a 1 year low of $255.96 and a 1 year high of $461.62.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share for the quarter, beating the consensus estimate of $4.14 by $0.55. UnitedHealth Group had a return on equity of 17.95% and a net margin of 3.53%. The firm had revenue of $112.70 billion for the quarter, compared to the consensus estimate of $111.31 billion. During the same quarter in the previous year, the company posted $2.59 EPS. The company's revenue for the quarter was down .4% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. Equities analysts forecast that UnitedHealth Group Incorporated will post 20.62 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 22nd. Stockholders of record on Monday, September 14th were paid a $2.32 dividend. The ex-dividend date of this dividend was Monday, September 14th. This represents a $9.28 annualized dividend and a dividend yield of 2.3%. UnitedHealth Group's dividend payout ratio is currently 53.00%.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on the company. Deutsche Bank Aktiengesellschaft increased their price target on UnitedHealth Group from $370.00 to $467.00 and gave the company a "hold" rating in a research note on Friday, July 17th. DA Davidson set a $512.00 price objective on UnitedHealth Group in a report on Tuesday, July 21st. Bank of America reissued a "buy" rating and issued a $450.00 target price on shares of UnitedHealth Group in a report on Monday, July 20th. Mizuho boosted their price target on shares of UnitedHealth Group from $493.00 to $500.00 and gave the stock an "outperform" rating in a research report on Thursday, October 22nd. Finally, Erste Group Bank lowered shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a research report on Thursday, August 27th. Twenty equities research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $463.93.

About UnitedHealth Group

UnitedHealth Group Incorporated NYSE: UNH is a diversified health care company that provides health insurance coverage, health care services, pharmacy services and health technology. Its businesses serve individuals, employers, government programs, health care providers and other organizations, primarily in the United States.

The company operates through two principal businesses. UnitedHealthcare offers health benefit plans and related services for employers, individuals, families and government-sponsored programs, including Medicare and Medicaid.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.